Mainz Biomed (MYNZ) Short Interest Ratio & Short Volume $0.24 0.00 (-0.83%) (As of 03:39 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends Mainz Biomed Short Interest DataMainz Biomed (MYNZ) has a short interest of 1.70 million shares, representing 9.74% of the float (the number of shares available for trading by the public). This marks a -25.11% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.9, indicating that it would take 0.9 days of the average trading volume of 924,969 shares to cover all short positions.Current Short Interest1,700,000 sharesPrevious Short Interest2,270,000 sharesChange Vs. Previous Month-25.11%Dollar Volume Sold Short$487,900.00Short Interest Ratio0.9 Days to CoverLast Record DateOctober 15, 2024Float Size17,460,000 sharesShort Percent of Float9.74%Today's Trading Volume1,008,957 sharesAverage Trading Volume924,969 sharesToday's Volume Vs. Average109% Short Selling Mainz Biomed? Sign up to receive the latest short interest report for Mainz Biomed and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMYNZ Short Interest Over TimeMYNZ Days to Cover Over TimeMYNZ Percentage of Float Shorted Over Time Ad WealthPressCould TSLA reach $500 a share? Free ebook says it’s possible.Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.To claim your copy, follow this link Mainz Biomed Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20241,700,000 shares $487,900.00 -25.1%9.7%0.9 $0.29 9/30/20242,270,000 shares $565,230.00 +215.0%13.2%1.3 $0.25 9/15/2024720,600 shares $219,638.88 +75.9%4.2%0.4 $0.30 8/31/2024409,600 shares $144,875.52 +26.2%2.4%0.3 $0.35 8/15/2024324,500 shares $103,840.00 -12.3%1.9%0.3 $0.32 7/31/2024369,900 shares $172,595.34 -54.9%2.2%0.4 $0.47 Get the Latest News and Ratings for MYNZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mainz Biomed and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024820,900 shares $354,628.80 +111.7%4.8%1.3 $0.43 6/30/2024387,800 shares $155,507.80 +37.4%2.3%0.8 $0.40 6/15/2024282,200 shares $176,375.00 -33.7%1.7%1.4 $0.63 5/31/2024425,700 shares $370,018.44 +41.5%2.5%2.7 $0.87 5/15/2024300,900 shares $191,974.20 -25.5%1.8%2.5 $0.64 4/30/2024404,100 shares $355,567.59 +34.0%2.6%3.6 $0.88 4/15/2024301,500 shares $295,470.00 -1.9%2.3%3.6 $0.98 3/31/2024307,300 shares $316,519.00 -3.1%2.3%3.5 $1.03 3/15/2024317,100 shares $329,784.00 -8.7%2.8%3.5 $1.04 2/29/2024347,200 shares $306,959.52 -17.6%3.0%2.8 $0.88 2/15/2024421,500 shares $421,500.00 -16.1%3.7%2.1 $1.00 1/31/2024502,100 shares $487,037.00 -14.9%4.4%2 $0.97 1/15/2024589,900 shares $704,930.50 +8.0%5.2%2.5 $1.20 12/31/2023546,100 shares $633,476.00 +68.6%4.8%2.4 $1.16 12/15/2023324,000 shares $336,960.00 +112.6%2.8%1.4 $1.04 11/30/2023152,400 shares $173,736.00 +10.0%1.3%0.5 $1.14 11/15/2023138,600 shares $167,706.00 +78.2%1.2%0.7 $1.21 10/31/202377,800 shares $156,378.00 -29.2%0.7%0.6 $2.01 10/15/2023109,900 shares $254,968.00 -12.1%1.0%0.9 $2.32 9/30/2023125,000 shares $365,000.00 -57.7%1.1%1 $2.92 9/15/2023295,700 shares $1.05 million +682.3%2.7%2.6 $3.54 8/31/202337,800 shares $115,668.00 +65.8%0.3%1.2 $3.06 8/15/202322,800 shares $71,820.00 +168.2%0.2%0.9 $3.15 7/31/20238,500 shares $36,210.00 -52.3%0.1%0.4 $4.26 7/15/202317,800 shares $87,220.00 +11.3%0.2%0.6 $4.90 6/30/202316,000 shares $76,480.00 -35.5%0.1%0.5 $4.78 6/15/202324,800 shares $121,520.00 -12.4%0.2%0.6 $4.90 5/31/202328,300 shares $155,367.00 -28.4%0.3%0.6 $5.49 5/15/202339,500 shares $216,855.00 +208.6%0.4%0.8 $5.49 4/30/202312,800 shares $50,816.00 -67.0%0.1%0.3 $3.97 4/15/202338,800 shares $230,472.00 -23.2%0.4%0.9 $5.94 3/31/202350,500 shares $317,140.00 +155.1%0.7%1.3 $6.28 3/15/202319,800 shares $124,344.00 -18.5%0.3%0.7 $6.28 2/28/202324,300 shares $172,287.00 +88.4%0.3%0.9 $7.09Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover 2/15/202312,900 shares $88,365.00 +76.7%0.2%0.6 $6.85 1/31/20237,300 shares $48,180.00 -21.5%N/A0.5 $6.60 1/15/20239,300 shares $61,566.00 +304.4%N/A0.6 $6.62 12/30/20222,300 shares $16,330.00 -60.3%N/A0.1 $7.10 12/15/20225,800 shares $44,254.00 -71.1%N/A0.3 $7.63 11/30/202220,100 shares $176,277.00 +27.2%N/A1 $8.77 11/15/202215,800 shares $123,398.00 -6.0%N/A0.8 $7.81 10/31/202216,800 shares $119,280.00 -2.9%N/A0.7 $7.10 10/15/202217,300 shares $121,273.00 +1.8%N/A0.7 $7.01 9/30/202217,000 shares $117,130.00 -30.9%N/A0.6 $6.89 9/15/202224,600 shares $214,543.98 -32.2%N/A0.9 $8.72 8/31/202236,300 shares $318,714.00 -17.1%N/A1.2 $8.78 8/15/202243,800 shares $404,712.00 +13.5%N/A1.6 $9.24 7/31/202238,600 shares $364,766.14 +6.3%N/A1.5 $9.45 7/15/202236,300 shares $332,145.00 -5.2%N/A1.3 $9.15 6/30/202238,300 shares $354,275.00 +60.9%N/A1.3 $9.25 6/15/202223,800 shares $244,902.00 -31.0%N/A0.8 $10.29 5/31/202234,500 shares $399,165.00 -23.8%N/A1 $11.57 5/15/202245,300 shares $508,492.50 -4.2%N/A1 $11.23 4/30/202247,300 shares $588,412.00 -27.8%N/A0.6 $12.44 4/15/202265,500 shares $927,486.55 +42.7%N/A0.5 $14.16 3/31/202245,900 shares $671,517.00 -13.6%N/A0.2 $14.63 3/15/202253,100 shares $709,947.00 -5.5%N/A0.1 $13.37 2/28/202256,200 shares $800,850.00 -13.9%N/A0.1 $14.25 2/15/202265,300 shares $1.01 million +63.7%N/A0.1 $15.49 1/31/202239,900 shares $627,228.00 +10.2%N/A0.1 $15.72 1/15/202236,200 shares $755,494.00 +133.6%N/A0 $20.87 12/31/202115,500 shares $161,045.00 No ChangeN/A0 $10.39 MYNZ Short Interest - Frequently Asked Questions What is Mainz Biomed's current short interest? Short interest is the volume of Mainz Biomed shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 1,700,000 shares of MYNZ short. 9.74% of Mainz Biomed's shares are currently sold short. Learn More on Mainz Biomed's current short interest. What is a good short interest ratio for Mainz Biomed? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MYNZ shares currently have a short interest ratio of 1.0. Learn More on Mainz Biomed's short interest ratio. What is a good short interest percentage for Mainz Biomed? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.74% of Mainz Biomed's floating shares are currently sold short. Is Mainz Biomed's short interest increasing or decreasing? Mainz Biomed saw a decline in short interest in October. As of October 15th, there was short interest totaling 1,700,000 shares, a decline of 25.1% from the previous total of 2,270,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Mainz Biomed's float size? Mainz Biomed currently has issued a total of 0 shares. Some of Mainz Biomed's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mainz Biomed currently has a public float of 17,460,000 shares. How does Mainz Biomed's short interest compare to its competitors? 9.74% of Mainz Biomed's shares are currently sold short. Here is how the short interest of companies compare to Mainz Biomed: Alvotech (0.07%), Pharvaris (0.73%), Lucid Diagnostics Inc. (5.73%), Biodesix, Inc. (0.29%), Sera Prognostics, Inc. (5.67%), Celcuity Inc. (9.53%), Guardant Health, Inc. (11.12%), and Exact Sciences Co. (8.41%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Mainz Biomed stock? Short selling MYNZ is an investing strategy that aims to generate trading profit from Mainz Biomed as its price is falling. MYNZ shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mainz Biomed? A short squeeze for Mainz Biomed occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MYNZ, which in turn drives the price of the stock up even further. How often is Mainz Biomed's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MYNZ, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies ATNFW Short Squeeze ALVOW Short Squeeze ALVO Short Squeeze ACABW Short Squeeze BFRIW Short Squeeze BCTXW Short Squeeze CELUW Short Squeeze CLNNW Short Squeeze CYTHW Short Squeeze DRMAW Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MYNZ) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredNASDAQ small cap that could be gearing up for a massive short squeeze.A Heavy Short Interest Could Lead to a Monstrous Short Squeeze for this Tiny NASDAQ Healthcare Firm!Huge Alerts | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mainz Biomed Please log in to your account or sign up in order to add this asset to your watchlist. Share Mainz Biomed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MYNZ Stock Alerts